Ibogaine in Australia

Schedule 4, and what it is not

Australia classifies medicines and poisons through the Poisons Standard, also called the SUSMP, maintained by the Therapeutic Goods Administration. Substances are placed in numbered schedules according to the level of control they need.

Ibogaine is in Schedule 4: Prescription Only Medicine, the same category as most ordinary prescription drugs.

We have not been able to establish the date ibogaine entered Schedule 4. Its current Schedule 4 status is certain, and we read it in the instrument itself; the date is not, and we would rather say so than repeat a year we cannot support.

This is the origin of one of the most persistent errors about ibogaine. Several widely-read sources list Australia among the countries where ibogaine is “legal”. Partnership to End Addiction’s drugfree.org page, updated in April 2026, says “Ibogaine is legal in Australia, Finland, New Zealand and Uruguay”. Schedule 4 is not legality in the sense a reader takes from that word. It is control by prescription.

The gap between schedule and supply

As in Canada and New Zealand, prescription control does not imply an approved product.

No ibogaine product appears on the Australian Register of Therapeutic Goods. A prescriber wishing to supply it would be dealing in an unapproved therapeutic good, which Australia permits through specific access pathways but which imposes its own requirements and its own liability.

So Schedule 4 describes a lawful route on paper. Walking it requires finding an Australian prescriber willing to take personal responsibility for an unapproved drug whose principal risk is fatal arrhythmia. That is a small number of people, and the schedule does not help you find them.

The state layer

The Poisons Standard is a national instrument, but it does not by itself create offences. Each state and territory gives it force through its own drugs and poisons legislation, and each may vary it.

The TGA publishes the variations, and no state or territory varies ibogaine’s scheduling: the only departures on that list concern kava in the ACT, cannabis for licensed research in Tasmania, and a native plant in Western Australia. For anyone assessing their own position, the national schedule tells you the category and the state legislation tells you the consequences, which differ more than a uniform standard suggests. Two states show how far they can diverge.

Victoria’s provision names Schedule 4 poisons as a class, so ibogaine is caught the moment it enters Schedule 4. New South Wales built a closed list instead, and never added ibogaine to it.

Importing it

The border regime is stricter than the schedule, and this is where accounts of Australia’s position usually go wrong.

Ibogaine appears on the Office of Drug Control’s list of controlled substances, classified as a narcotic for import purposes. Bringing it in requires both an import licence and an import permit from the ODC, on top of a TGA approval under the Special Access Scheme or the Authorised Prescriber scheme.

A package ordered from an overseas website meets none of that, and the personal importation scheme does not rescue it. The regulation exempts a drug carried by a passenger for their own medical treatment on a practitioner’s prescription, and nothing else a private person is likely to rely on. Ibogaine’s Schedule 4 status inside Australia sits alongside a border regime that treats it as a narcotic.

Australia in context

Australia belongs with Canada, New Zealand and South Africa in the prescription group. Of the four it is the one most often misreported as permissive, probably because “Schedule 4” reads to a non-Australian like a low number on a prohibition scale rather than what it is.

See the status by country table for the full picture, and New Zealand for the same approach documented in more detail by its regulator.